Abstract To determine the variability in processes of care in the last 6 months of life experienced by patients dying of primary intracranial tumors and potential predictors of place of death, a death-backwards cohort was assembled using historical data and 1,623 decedents were identified. 90 % of people had C1 admission to an acute care hospital and 23 % spent C3 months of their last 6 months of life in acute care. 44 % had C1 ER visits and 30 % were admitted C1 times to ICU. Only 18 % had a home visit by a physician. 10 % died at home but 49 % died in hospital, while 40 % died in a palliative care facility. Age, comorbidities, and being diagnosed with grade 4 astrocytoma were associated with greater burden of care. Level of care burden and age were associated with higher odds of dying in a treatment intensive place of death, being diagnosed with grade 4 astrocytoma had opposite effect. Despite valuable research efforts to improve the treatment of primary intracranial tumors that focus on biology, refinements to surgery, radiation, and chemotherapy, there is also room to improve aspects of care at the end of life situation. An integrative approach for this patients' population, from diagnosis to death, could potentially reduce the care burden in the final period on the health care system, patient's family and improve access to a better place of death.
Introduction
Advances in technology have made earlier diagnosis of cancer possible, management is increasingly multimodal and multidisciplinary, and the population is aging, especially in high-income societies. These secular changes have increased complexity of care and diversity of population seeking care; more so, regarding the care of the dying.
People with intracranial tumors (ICT) have the same ''general tumor symptoms'' as people with other types of tumors, but they also experience consequences of focal neurological deficits, such as motor deficit, aphasia, etc. Because of these sequelae, the functional impact of ICT is much more widespread than that of other of cancers. In the last stage of disease, they may become functionally dependent due to tumor progression or treatment side effects, indicating an even greater need for palliative and supportive care [1] .
Improving end of life (EOL) experience is a major challenge to health care systems. Deaths that are reasonably free of discomfort, in accordance with patients' wishes, and within acceptable professional and ethical standards are considered high-quality deaths [2] . Promoting quality of life and reducing the burden of care to the patient are pivotal to the philosophy of EOL care [3] . How much has this philosophy influenced the care received by patients with ICT?
Prospective studies, while optimal for addressing questions about EOL care are costly and difficult to execute. A retrospective approach is an efficient way to monitor EOL care across jurisdictions, demographic groups and time periods [4] .
The clinical information available in administrative databases can provide relevant answers to questions about processes of care at EOL; such studies are feasible, and allow the study of the whole population at a reasonable cost [3, 5] . A limitation is that not all elements characterizing the care received by the patient are directly documented. However, certain elements of care that reflect provision of palliative care are available and can be used as indicators of the quality of EOL cancer care and could be extracted from administrative databases. One feature of high quality EOL care is the possibility of a patient remaining at home or other place that fosters dying in relative comfort and dignity. On the contrary, frequent emergency room (ER) visits or admissions to hospital near the EOL are considered indicators of less than optimal EOL cancer care.
The primary aim of this study is to determine, using administrative data in the province of Quebec, Canada, the variability in processes of care in last 6 months of life of persons dying of primary ICT, where processes of care are characterized by:
• Interventions received • Place of death • Frequency of Intensive Care Unit (ICU) admissions and ER visits • Duration of hospitalizations prior to death • Involvement of specialists in care • Frequency and type of ambulatory care visits.
The secondary aim is to identify determinants of more optimal processes of care and factors that potentially predict the place of death.
Methods

Data sources
In Canada, coverage for health care services is universal. Each province maintains, for reimbursement purposes, its own set of health databases covering hospital services, feefor-service billings for visits, tests and procedures, and prescriptions filled. For the purpose of identifying services provided at EOL for people with ICT, linkage between the death registry, the hospital discharge database (MedEcho 1 ) and the billing databases maintained by RAMQ 2 was carried out. The death registry lists principle cause of death. MedEcho contains coded information of all hospital separations. There are data fields for the Medicare number of the subject (NAM), final diagnoses and 14 secondary diagnoses, topography codes serving as specific identification of cancer diagnosis and sites of metastases, dates of admission and discharge, type of bed (e.g. Acute Care Unit -ACU-) during hospitalization, status at discharge (alive or dead), discharge destination (e.g. home), age, gender, regional indicators, and procedures. Type of institution (acute vs chronic care) is also coded.
RAMQ databases contain, among other things, the NAM (identical to the NAM in MedEcho); a beneficiary file containing all fees for services received (code of act), site of act, and specialty of physician performing the act (licensing information). The linkage of the databases is done at the ministry level through the NAM, and the merged file is provided with an identification number that is denominalized to respect confidentiality.
Validity and completeness of RAMQ database have been verified and shown to be high [6, 7] .
Design
A death-backwards cohort was assembled using historical data from the three health administration databases for years [2003] [2004] [2005] [2006] , inclusive. The study time interval was selected to reflect cancer evolution before death. In general, cancer patients experience a marked decline in their physical function in their last 6 months of life [8] .
Procedures Figure 1 shows how records for inclusion in the primary intracranial tumor EOL study were chosen. From the two data sources on hand, death registry (box a: n = 67,655) and hospitalization database (box b: n = 83,566), an algorithm using ICD codes was applied (box c) to extract those records of people diagnosed with a single ICT (box d: n = 1,922 and box e: n = 468). From the hospitalization group (box e), we included only those deaths that could be attributed to the disease or treatment (box f). To the records arising from both data sources, histology codes were consulted to identify those with a proven primary ICT thereby eliminating those with a single intracranial metastatic lesion (box g) yielding 1,607 records from death certificates (box h) and 106 records from hospitalization data (box i). The records in box i were further scrutinized to eliminate people whose death may have been causes not related to the disease or its treatment (box k: n = 90) and may have ''died with'' their tumor. The final death-backwards cohort comprised 1,623 people (box j). Table 5 in Appendix shows the ICD-9 and 10 codes for selecting records for single ICT (box c); Table 6 in Appendix provides the histology codes (box g). Table 7 in Appendix provides the list of diagnostic codes encountered in EOL situations for ICT, which would satisfy the condition for dying of the disease or its treatment side effects (e.g. septic complications). Diagnoses excluded from this list were related to chronic progressive diseases that by themselves lead to death such as COPD, dementia, etc. People with final diagnoses not related to pathologies listed in Table  7 in Appendix were considered to have died with primary ICT.
Measures
Two outcomes indicative of quality of EOL care were care burden (CB) and place of death. The CB outcome was created to reflect the impact of care processes on the patient [9] rather than that of the health care system. An estimate of CB for each subject was created using characteristics of care during the last 6 months of life, based on: number of ICU admissions (0-3), ER visits (0-7), duration of hospital stay in months (0-6), neurosurgical interventions received (0-3), radiotherapy received (0-1), oncologist consultation (0-1), neurosurgeon consultation (0-1). The CB was an ordinal variable ranging from 0 (low burden) to 13 (high burden) ( Table 8 in Appendix).
Place of death was an ordinal variable ordered from worst (ER = 5) to best (home = 0), with dying in ACU (4), chronic care (3), palliative care unit (PCU) (2) , and hospice (1), as intermediate categories. Potential predictors were: age, gender, residence, comorbidity, social and material deprivation indices and tumor type. A comorbidity score was created for each subject using the Romano-Roos Dartmouth-Manitoba modification of the Charlson comorbidity index to include all available diagnostic information. Social and material deprivation indices were assessed by using the method developed in Canada by Pampalon et al. [10] . Quintile 1 represents the most privileged population and quintile 5, the least. For this study, we covered the 5 years preceding death. Tumor type was identified from the histology codes and was dichotomized into either grade 4 glioma (GBM) or not.
Hospital of origin and year of death were also identified to account for them in the analysis as potential confounders for both place of death and the level of CB. Hospital was assigned based on neurosurgical interventions during the 5 years prior to death; if there was more than one, the last intervention was chosen. In total, 1,155 subjects were linked to 11 hospitals using neurosurgical information; 310 were linked to these 11 hospitals using other data (e.g. ICU admissions); and the remaining 159 people were classified as receiving care at other hospitals.
Statistical analysis
The analysis related two ordinal outcomes, level of CB, and place of death with key explanatory variables using ordinal regression model [11] . The proportional odds model was chosen to estimate the cumulative proportional odds ratio (CPOR) for outcome (with k categories) as a function of predictors. The predictors were scored to reflect the odds of increased CB or unfavorable place of death with respect to categories of predictors. The CPOR is interpreted as the odds of a poorer outcome for one level of a predictor relative to the odds for another level of the predictor, regardless of how ''poorer'' outcome is defined. A v 2 test of homogeneity of the CPOR across levels of the outcomes was carried out, however, as this test is known to be overly sensitive to sparse cells [11] , the consistency of the odds ratios across cut points was verified by inspection.
For each level of predictor a reference category was defined based on convention or distribution.
All predictors were dummy coded. For place of death, two models were considered, excluding and including CB as a predictor. All analyses were conducted using SAS Ò 9.2 statistical software package.
Results
Demographic characteristics
Between 2003 and 2006, 1,623 people died from primary ICT or their treatment side effects. Table 1 provides key characteristics of the 1,065 people (65.6 %) who were diagnosed with GBM and the remaining diagnosed with other tumor types. Of note, 70 % of the sample was between 50 and 79 years of age, 57.4 % were men, the majority had an urban address (81 %) and 64.9 % had a Charlson Comorbidity Index of C3. The social and material deprivation indices showed the expected distribution by quintile. The distribution of the sample across hospital of care ranged from 2.9 to 19.6 %. Place of death distributed from least to most frequent, ER (1.1 %), home (9.8 %), hospice (11.9), chronic care (16.9 %), PCU (29.6 %), ACU (31 %). Table 2 shows distribution of the number of people receiving each type of health care encounters over the last 6 months of life and Table 3 shows the distribution according to place of death. For ICU admissions, 1,143 patients (70.4 %) had none, 385 (23.7 %) had one, and 95 (5.8 %) had C2, frequent admissions were noted for people who died in an ACU or ER. 106 patients had C3 ER visits; more visits for people who died in ER or ACU. 90 % of the population spent C1 month in the hospital over the 6 months period, more time in hospital is observed for people who died in PCU or ACU (none stayed less than 1 month). Of the people who died in ACU, 78.3 % stayed C1 week in the last admission leading to death.
Patients receiving ICT targeted treatments during this period represented 15.6 and 28 % of the total population for surgery and radiotherapy respectively. These treatments were more common for people who died in ER, PCU or ACU. 13.4 % of the population had C1 consultations with a neurosurgeon, 14.8 % with an oncologist in the last 6 months of life, noted more for people who died in an ACU or ER. 11.1 and 25.5 % had a consultation with a general practitioner (GP) or palliative care physicians, respectively. 19 % of the population had at least one home visit by a physician during this period, more for people who died at home and hospice. At the community level (outpatient clinic visits, emergency clinics, CLSC 3 ) [60 % of the patients had C1 visit by a specialist or a GP, more common for people who died in ER and at home (specialist) or ER and hospice (GP).
Factors modifying the level of care burden and place of death
The overall estimate of level of CB for each subject ranged from 0 to 13 (Table 8 in Appendix). The five highest scores (9-13) were grouped together as they contained a small numbers of subjects, leaving ten ordinal levels of CB (0-9). Table 4 
Discussion
Using administrative data, this study demonstrated that at the population level, there was considerable variability in the processes of care experienced by persons dying of primary ICT. One major finding in this study was the low rate of home deaths, 9.8 % represents one of the lowest documented in the literature and less then the expected average (18.8 %) in cancer studies and is approached only by studies from Quebec and Japan with a reported home death rate of 6.9 and 8.2 % respectively [3, 12] . In brain cancer studies, this study represents the lowest reported rate [13] [14] [15] . Several possible explanations for this low rate of home death could be extracted from the data: age ([60 % of subjects are above 60 years), high proportion of subjects needing to go to ER repeatedly, prolonged hospital inpatient duration, low involvement of GP and few home visits, as most of these factors have been associated with a lower probability of dying at home [12, [16] [17] [18] [19] . While it was not possible to document other factors such as presence of family caregivers or a subject's wishes, a study by Pritchard et al. [20] showed that the most important factor contributing to a low rate of home death is the accessibility and utilization of acute care beds. In the province of Quebec, the rate was 4.4 hospital beds per 1,000 inhabitants (2002), the definition of high accessibility is a rate of hospital beds of greater than 3.3 beds per 1,000 beneficiaries [21] . Thus, in this province the low home death rate is compatible with this high number of beds per population. Another potential explanation for the variability in place of death across various studies is the different national health systems.
Consultation with specialists in palliative care was low (25.5 %). This low rate, coupled with a comparably low rate of death in palliative care beds (hospice 11.9 % and PCU 29.6 %) suggests the will to refer, but still a scarcity of palliative care specialists working in cancer centers and ACU [3] .
It should be emphasized that the level of CB is simply a numeric approach to summarize processes of care that have been indicated in the literature as being poor EOL quality care (frequent ER and ICU admissions, high number of hospital days near the EOL) [5] or cure oriented processes (interventions, specialists involvement near the EOL) [22] . It was constructed for the purposes of facilitating statistical analysis and to assess factors that potentially affect it, it was not intended as a measure of CB, rather a statistical indicator of this construct. Others are working on quantifying and qualifying burden of treatment for different chronic conditions [9, 23] and more research needs to be done on this construct as it relates to cancer in general and to EOL.
The results of the analyses on factors contributing to the level of CB provide evidence that: older age, greater comorbidities, and type of tumor (GBM) were associated with higher burden. These factors have also been found to affect the functional status of the patient and subsequently increase the likelihood of being dependent near the EOL with the expected increase in CB (more ER visits, increasing time in hospital, etc.) [24, 25] .
Other studies have also found that terminal cancer patients who died in a hospital spent more of their final life in the hospital than those who died at home [26] [27] [28] . Cure oriented processes were likely to be associated with death at places other than home [29] . Contradictory findings were documented in published studies of adult cancer patients regarding age as the influencing factor on place of death. Some studies concluded that the probability of dying in the hospital diminished with increasing age, [30, 31] others found that the probability of dying at home diminished with age [32] . Costantini and colleagues [33] concluded that the proportion of home deaths significantly increased with increasing age at death. To add to the controversy, many studies demonstrated no significant difference in the average age between homedeath and hospital-death groups [29, 34] . Age is likely a proxy variable for a number of other unmeasured factors such as social support and health-care network. Type of cancer is likely to influence the place of death through symptoms, complication, and functional status, however, the relationship of specific diagnosis and place of death is not conclusive [29, [32] [33] [34] , Hematological malignancies were the only diagnosis that had been repeatedly shown to predict hospital death, as patients often die from complications, such as infection, that tend to precipitate readmission to the hospital [29, [32] [33] [34] . Many theories have been proposed to explain the lack of congruence of relationships between diagnosis and place of death [33, 35] . A longer prognosis allows the family to organize the care at home. Slow progression of disease would allow progressive mental adjustment and the development of the necessary skills to take care of patients at home. In contrast, the family may lack the economic, psychosocial, and emotional resources to care for the patient with slow progressing cancers at home for a prolonged period of time, resulting in terminal hospitalization. Other theories suggest that the likelihood of death at home was positively associated with longer periods of survival after diagnosis and that patients with a shorter survival time were more likely to die in a hospital. This study disprove this notion, that patients who died from GBM were likely to die in a less treatment invasive place of death (e.g. home or PCU). This may be because the patient and family are aware of the poor prognosis of GBM at time of diagnosis and prepare accordingly.
Limitations of using administrative databases have been highlighted elsewhere [36] [37] [38] . For this study, and to an extent other EOL care studies, the databases will not capture some of the information considered important by patients, families [39] and care providers, such as psychosocial care, multidisciplinary treatment, symptom management, spiritual well-being and advanced directives.
Nevertheless, this study opens an avenue that is convenient, generalizable, and efficient for evaluating and implementing performance indicators related to EOL care in this patients' population, with the caveat that this and all similar studies are based on data generated within a finite geographic, socioeconomic and cultural setting.
This study was successful, using existing administrative databases, in documenting important indicators of the level of CB, services provided at the EOL and there effect on place of death for patients died from primary ICT. An advantage of this type of study is that it is population-based and that the data are robust: physicians are paid on the basis of services rendered, and completeness and accuracy of reporting have monetary incentives attached.
Similar methodologies could be used to evaluate other health care delivery systems across providers, geographic areas, demographic groups, and time periods, to help promote better health care policies for the dying, and to monitor changes over time, especially after the introduction of these new health service policies. 
Appendix
See Tables 5, 6 , 7, and 8 Persons in other circumstances V60.0-V64.9 Z40-Z51
